奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

002755 奥赛康

已收盘 11-05 15:00:00

{"stockData":{"symbol":"002755","market":"SZ","secType":"STK","nameCN":"奥赛康","latestPrice":12.79,"timestamp":1793862186000,"preClose":12.45,"halted":0,"volume":9493605,"delay":0,"changeRate":0.0273,"floatShares":927999999,"shares":927999999,"eps":0.1969,"marketStatus":"已收盘","change":0.34,"latestTime":"11-05 15:00:00","open":12.49,"high":12.93,"low":12.48,"amount":121000000,"amplitude":0.0361,"askPrice":12.8,"askSize":965,"bidPrice":12.79,"bidSize":558,"shortable":0,"etf":0,"ttmEps":0.1969,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1793928600000},"marketStatusCode":5,"adr":0,"adjPreClose":12.45,"symbolType":"stock","openAndCloseTimeList":[[1793842200000,1793849400000],[1793854800000,1793862000000]],"highLimit":13.7,"lowLimit":11.21,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":928160351,"isCdr":false,"pbRate":3.53,"roa":"--","peRate":64.956831,"roe":"5.22%","epsLYR":0.25,"committee":-0.297864,"marketValue":11871000000,"turnoverRate":0.0102,"status":0,"floatMarketCap":11871000000},"requestUrl":"/m/hq/s/002755","defaultTab":"news","newsList":[{"id":"2680037684","title":"奥赛康(002755.SZ)：创新药奥美妥塔单抗上市许可申请获得受理","url":"https://stock-news.laohu8.com/highlight/detail?id=2680037684","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680037684?lang=zh_cn&edition=full","pubTime":"2026-11-04 19:03","pubTimestamp":1793790224,"startTime":"0","endTime":"0","summary":"智通财经APP讯，奥赛康(002755.SZ)发布公告，公司子公司江苏奥赛康生物医药有限公司于近日收到国家药品监督管理局下发的《受理通知书》，公司创新药奥美妥塔单抗的境内生产药品注册上市许可申请获得受理。奥美妥塔单抗注射液，英文通用名为Omectatug;奥美妥塔单抗注射液联合 CAPOX(氟尿嘧啶类和铂类药物)及替雷利珠单抗在用于既往未接受过系统治疗的CLDN18.2阳性、不可切除的局部晚期、复发性或转移性胃及食管胃交界处腺癌患者一线治疗的关键性III期临床试验中，已达到独立评审委员会(IRC)评估的无进展生存期(PFS)主要终点。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1518557.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0028","06978","BK0239","BK1161","LNGR","IBBQ","IPOS","159992","MEDX","002755","BK1574"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2680678577","title":"股市必读：奥赛康（002755）11月2日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2680678577","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2680678577?lang=zh_cn&edition=full","pubTime":"2026-11-03 02:52","pubTimestamp":1793645536,"startTime":"0","endTime":"0","summary":"截至2026年11月2日收盘，奥赛康报收于11.91元，上涨2.23%，换手率0.77%，成交量7.11万手，成交额8350.92万元。董秘最新回复投资者： 请问公司截止2026年10月20日的股东户数是多少？当日关注点交易信息汇总：11月2日主力资金净流出170.88万元，占总成交额2.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026110300004874.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679225791","title":"奥赛康（002755）2026年三季报简析：净利润同比下降24.14%，盈利能力上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2679225791","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679225791?lang=zh_cn&edition=full","pubTime":"2026-10-31 07:47","pubTimestamp":1793404055,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期奥赛康发布2026年三季报。截至本报告期末，公司营业总收入12.48亿元，同比下降12.99%，归母净利润1.69亿元，同比下降24.14%。按单季度数据看，第三季度营业总收入3.77亿元，同比下降11.69%，第三季度归母净利润4876.36万元，同比下降23.0%。本报告期奥赛康盈利能力上升，毛利率同比增幅1.76%，净利率同比增幅0.08%。本文数据来源于奥赛康2026年三季报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026103100017027.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679403138","title":"奥赛康(002755)10月20日股东户数3.34万户，较上期减少5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679403138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679403138?lang=zh_cn&edition=full","pubTime":"2026-10-29 19:08","pubTimestamp":1793272095,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年10月20日公司股东户数为3.34万户，较10月10日减少1989.0户，减幅为5.61%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.95万户。从股价来看，2026年10月10日至2026年10月20日，奥赛康区间跌幅为7.87%，在此期间股东户数减少1989.0户，减幅为5.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900045925.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2679860415","title":"图解奥赛康三季报：第三季度单季净利润同比下降23.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2679860415","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2679860415?lang=zh_cn&edition=full","pubTime":"2026-10-29 03:08","pubTimestamp":1793214498,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康2026年三季报显示，前三季度公司主营收入12.48亿元，同比下降12.99%；归母净利润1.69亿元，同比下降24.14%；扣非净利润1.46亿元，同比下降21.26%；其中2026年第三季度，公司单季度主营收入3.77亿元，同比下降11.69%；单季度归母净利润4876.36万元，同比下降23.0%；单季度扣非净利润3977.62万元，同比下降11.25%；负债率23.58%，投资收益374.93万元，财务费用-860.23万元，毛利率81.2%。财报数据概要请见下图:本文数据来源于奥赛康2026年三季报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102900003717.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677285269","title":"奥赛康(002755)10月20日股东户数3.34万户，较上期减少5.61%","url":"https://stock-news.laohu8.com/highlight/detail?id=2677285269","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677285269?lang=zh_cn&edition=full","pubTime":"2026-10-23 17:58","pubTimestamp":1792749538,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年10月20日公司股东户数为3.34万户，较10月10日减少1989.0户，减幅为5.61%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至10月20日，化学制药行业平均股东户数为3.67万户。从股价来看，2026年10月10日至2026年10月20日，奥赛康区间跌幅为7.87%，在此期间股东户数减少1989.0户，减幅为5.61%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300032807.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677913957","title":"奥赛康：截至10月20日，公司股东人数为33,448户","url":"https://stock-news.laohu8.com/highlight/detail?id=2677913957","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677913957?lang=zh_cn&edition=full","pubTime":"2026-10-23 08:48","pubTimestamp":1792716492,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)10月22日在投资者关系平台上答复投资者关心的问题。投资者提问：截止10.20贵司股东户数有多少奥赛康回复：您好，截至10月20日，公司股东人数为33,448户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300008405.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2677441998","title":"股市必读：奥赛康（002755）10月22日收盘跌5.15%，主力净流出1266.98万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2677441998","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2677441998?lang=zh_cn&edition=full","pubTime":"2026-10-23 01:55","pubTimestamp":1792691712,"startTime":"0","endTime":"0","summary":"截至2026年10月22日收盘，奥赛康报收于11.79元，下跌5.15%，换手率1.25%，成交量11.57万手，成交额1.39亿元。交易信息汇总股价提醒10月22日奥赛康收盘报11.79元，跌5.15%，当日成交1.39亿元。前10个交易日主力资金累计净流出342.52万元，股价累计下跌5.15%；融资余额累计增加907.62万元，融券余量累计增加1.21万股。资金流向10月22日主力资金净流出1266.98万元，占总成交额9.1%；游资资金净流出265.66万元，占总成交额1.91%；散户资金净流入1532.65万元，占总成交额11.0%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102300002130.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676638878","title":"股市必读：奥赛康(002755)股东户数3.54万户，较上期增加9.3%","url":"https://stock-news.laohu8.com/highlight/detail?id=2676638878","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676638878?lang=zh_cn&edition=full","pubTime":"2026-10-20 01:19","pubTimestamp":1792430348,"startTime":"0","endTime":"0","summary":"截至2026年10月19日收盘，奥赛康报收于12.36元，下跌2.83%，换手率1.49%，成交量13.87万手，成交额1.72亿元。股本股东变化：截至2026年10月10日，奥赛康股东户数为3.54万户，较9月30日增加9.3%。股本股东变化股东户数变动截至2026年10月10日，奥赛康股东户数为3.54万户，较9月30日增加3015.0户，增幅9.3%；户均持股数量由2.86万股减少至2.62万股，户均持股市值为34.94万元。谢谢董秘： 您好，截至10月10日，公司股东人数为35,437户，感谢您对公司的关注！","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026102000001768.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2676186572","title":"奥赛康：截至10月10日，公司股东人数为35,437户","url":"https://stock-news.laohu8.com/highlight/detail?id=2676186572","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2676186572?lang=zh_cn&edition=full","pubTime":"2026-10-19 11:36","pubTimestamp":1792380996,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)10月19日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2026年10月10日公司的股东人数是多少？谢谢奥赛康回复：您好，截至10月10日，公司股东人数为35,437户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101900010763.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2674876820","title":"奥赛康(002755)9月30日股东户数3.24万户，较上期减少3.8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2674876820","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2674876820?lang=zh_cn&edition=full","pubTime":"2026-10-12 17:41","pubTimestamp":1791798113,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年9月30日公司股东户数为3.24万户，较9月18日减少1281.0户，减幅为3.8%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年9月18日至2026年9月30日，奥赛康区间涨幅为19.7%，在此期间股东户数减少1281.0户，减幅为3.8%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026101200023634.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","BK0239","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049407","title":"奥赛康（002755）9月30日主力资金净买入7190.40万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049407","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049407?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:01","pubTimestamp":1791421306,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，奥赛康报收于13.55元，上涨9.98%，涨停，换手率2.03%，成交量18.85万手，成交额2.48亿元。9月30日的资金流向数据方面，主力资金净流入7190.4万元，占总成交额28.94%，游资资金净流出3323.36万元，占总成交额13.38%，散户资金净流出3867.04万元，占总成交额15.56%。近5日资金流向一览见下表：奥赛康融资融券信息显示，融资方面，当日融资买入654.23万元，融资偿还1636.43万元，融资净偿还982.2万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002842.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671322106","title":"异动快报：奥赛康（002755）9月30日10点23分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2671322106","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2671322106?lang=zh_cn&edition=full","pubTime":"2026-09-30 10:25","pubTimestamp":1790735131,"startTime":"0","endTime":"0","summary":"证券之星9月30日盘中消息，10点23分奥赛康（002755）触及涨停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为创新药，幽门螺杆菌概念，医药概念热股，当日创新药概念上涨2.76%，幽门螺杆菌概念概念上涨2.54%，医药概念上涨2.53%。9月29日的资金流向数据方面，主力资金净流出545.37万元，占总成交额5.69%，游资资金净流出51.24万元，占总成交额0.53%，散户资金净流入596.61万元，占总成交额6.22%。近5日资金流向一览见下表：奥赛康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026093000011510.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0028","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430779","title":"奥赛康（002755）9月23日主力资金净卖出2820.22万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430779","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430779?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:20","pubTimestamp":1790212828,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月23日收盘，奥赛康报收于12.97元，下跌3.14%，换手率2.36%，成交量21.86万手，成交额2.86亿元。9月23日的资金流向数据方面，主力资金净流出2820.22万元，占总成交额9.86%，游资资金净流出3600.33万元，占总成交额12.58%，散户资金净流入6420.55万元，占总成交额22.44%。近5日资金流向一览见下表：奥赛康融资融券信息显示，融资方面，当日融资买入1819.56万元，融资偿还1781.87万元，融资净买入37.69万元，连续3日净买入累计638.84万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400009257.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["002755","BK0239","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669430350","title":"奥赛康：利厄替尼片两项适应症已纳入医保","url":"https://stock-news.laohu8.com/highlight/detail?id=2669430350","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669430350?lang=zh_cn&edition=full","pubTime":"2026-09-24 09:01","pubTimestamp":1790211679,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)09月23日在投资者关系平台上答复投资者关心的问题。投资者提问：＂请问利厄替尼片2026H1销售收入是多少？进院进度如何？＂奥赛康回复：您好，利厄替尼片两项适应症已纳入医保，并于2026年1月1日起正式执行，依托国家创新药支持政策，公司持续推进终端覆盖，院内和双通道药房销售工作有序开展，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092400008773.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669108803","title":"研报掘金丨东海证券：首予奥赛康“买入”评级，业绩短期承压，研发快速推进","url":"https://stock-news.laohu8.com/highlight/detail?id=2669108803","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669108803?lang=zh_cn&edition=full","pubTime":"2026-09-23 14:23","pubTimestamp":1790144630,"startTime":"0","endTime":"0","summary":null,"market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["161027","BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669130419","title":"异动快报：奥赛康（002755）9月21日14点5分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2669130419","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2669130419?lang=zh_cn&edition=full","pubTime":"2026-09-21 14:10","pubTimestamp":1789971053,"startTime":"0","endTime":"0","summary":"证券之星9月21日盘中消息，14点5分奥赛康（002755）触及涨停板。其所属行业化学制药目前上涨。领涨股为华仁药业。该股为创新药，医药，幽门螺杆菌概念概念热股，当日创新药概念上涨4.28%，医药概念上涨3.88%，幽门螺杆菌概念概念上涨3.71%。9月18日的资金流向数据方面，主力资金净流入999.06万元，占总成交额9.07%，游资资金净流出230.18万元，占总成交额2.09%，散户资金净流出768.88万元，占总成交额6.98%。近5日资金流向一览见下表：奥赛康主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026092100013211.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0028","002755"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667601058","title":"奥赛康(002755)9月10日股东户数3.33万户，较上期减少4.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2667601058","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667601058?lang=zh_cn&edition=full","pubTime":"2026-09-16 17:37","pubTimestamp":1789551450,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年9月10日公司股东户数为3.33万户，较8月31日减少1577.0户，减幅为4.52%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至9月10日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月31日至2026年9月10日，奥赛康区间涨幅为2.2%，在此期间股东户数减少1577.0户，减幅为4.52%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600027852.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0028","002755","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2667608241","title":"奥赛康：截至9月10日，公司股东人数为33,305户","url":"https://stock-news.laohu8.com/highlight/detail?id=2667608241","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2667608241?lang=zh_cn&edition=full","pubTime":"2026-09-16 15:07","pubTimestamp":1789542441,"startTime":"0","endTime":"0","summary":"证券之星消息，奥赛康(002755)09月15日在投资者关系平台上答复投资者关心的问题。投资者提问：截止9.10日贵司持股户数有多少？奥赛康回复：您好，截至9月10日，公司股东人数为33,305户，感谢您对公司的关注！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：沈彬","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091600018767.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666058905","title":"奥赛康(002755)8月31日股东户数3.49万户，较上期增加5.87%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666058905","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666058905?lang=zh_cn&edition=full","pubTime":"2026-09-09 17:28","pubTimestamp":1788946085,"startTime":"0","endTime":"0","summary":"证券之星消息，近日奥赛康披露，截至2026年8月31日公司股东户数为3.49万户，较8月20日增加1935.0户，增幅为5.87%。在化学制药行业个股中，奥赛康股东户数低于行业平均水平，截至8月31日，化学制药行业平均股东户数为3.64万户。从股价来看，2026年8月20日至2026年8月31日，奥赛康区间跌幅为18.71%，在此期间股东户数增加1935.0户，增幅为5.87%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090900029369.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","002755","BK0028"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1793883374102,"stockEarnings":[{"period":"1week","weight":0.0172},{"period":"1month","weight":-0.0812},{"period":"3month","weight":-0.054},{"period":"6month","weight":-0.2911},{"period":"1year","weight":-0.3423},{"period":"ytd","weight":-0.2303}],"compareEarnings":[{"period":"1week","weight":0.0013},{"period":"1month","weight":-0.0406},{"period":"3month","weight":-0.0549},{"period":"6month","weight":-0.1181},{"period":"1year","weight":-0.0692},{"period":"ytd","weight":-0.0712}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"北京奥赛康药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"33448人(较上一季度减少5.61%)","perCapita":"27749股","listingDate":"2015-05-15","address":"北京市丰台区南四环西路188号七区28号楼","registeredCapital":"92816万元","survey":"　　北京奥赛康药业股份有限公司的主营业务是原料药及制剂的研发、生产、销售。公司的主要产品是消化类、抗肿瘤类、抗感染类、慢性病类。公司11件主导产品核心专利技术分别荣获中国专利金奖1项、省专利项目奖金奖1项、省专利项目奖优秀奖3项、市优秀专利奖6项。","listedPrice":7.49},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.52.0","shortVersion":"4.52.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"奥赛康,002755,奥赛康股票,奥赛康股票老虎,奥赛康股票老虎国际,奥赛康行情,奥赛康股票行情,奥赛康股价,奥赛康股市,奥赛康股票价格,奥赛康股票交易,奥赛康股票购买,奥赛康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"奥赛康(002755)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供奥赛康(002755)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}